Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients
Flexible, fibreoptic bronchoscopy (FFB) and bronchoalveolar lavage (BAL) have been used for diagnostic purposes in critically ill ventilated patients. The additional diagnostic value compared to tracheal aspirations in ventilator-associated pneumonia (VAP) has been questioned. Nevertheless, BAL can...
Gespeichert in:
Veröffentlicht in: | BMC pulmonary medicine 2015-09, Vol.15 (1), p.107-107, Article 107 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 107 |
---|---|
container_issue | 1 |
container_start_page | 107 |
container_title | BMC pulmonary medicine |
container_volume | 15 |
creator | Schnabel, R M van der Velden, K Osinski, A Rohde, G Roekaerts, P M H J Bergmans, D C J J |
description | Flexible, fibreoptic bronchoscopy (FFB) and bronchoalveolar lavage (BAL) have been used for diagnostic purposes in critically ill ventilated patients. The additional diagnostic value compared to tracheal aspirations in ventilator-associated pneumonia (VAP) has been questioned. Nevertheless, BAL can provide extra information for the differential diagnosis of respiratory disease and good antibiotic stewardship. These benefits should outweigh potential hazards caused by the invasiveness of this diagnostic technique. The focus of the present study was on the clinical course and complications of patients following BAL procedures up to 24 h.
Hundred sixty-four FFB guided BAL procedures for suspected pneumonia were analysed in an observational study. The clinical course of patients was monitored by respiratory and haemodynamic data before BAL, 1 and 24 h after BAL. Complications were defined and registered. Factors associated with complications were analysed by logistic regression.
a decrease in average pO2/FiO2 ratio 1 h after BAL from 29 kPa (218 mmHg) to 25 kPa (189 mmHg) (p < 0.05) was observed which fully recovered within 24 h. Respiratory complications: the incidence of procedure related hypo-oxygenation (SaO2 ≤ 88 %) and/or bronchospasm was 9 %; a decrease of >25 % PaO2/FiO2 ratio 1 h after BAL was found in 29 % of patients; no bleeding or pneumothorax were registered. Haemodynamic complications: there were no cases of hypertension and cardiac rhythm disturbances; haemodynamic instability within the first 24 h after BAL was recorded in 22 %; this was correlated with a cardiovascular diagnosis at admission (OR 2.9; 95 % CI 1.2 - 6.7) and the presence of cardiovascular co-morbidity (OR 3.5; 95 % CI 1.5 - 8.3). The incidence of bacteraemia was 7 %. There was no case of procedure related death.
Frequently occurring haemodynamic and respiratory instability but no cases of cardiac rhythm disturbances, bleeding, pneumothorax or procedure related death were attributable to diagnostic FFB and BAL. The procedures should be conducted under careful supervision by experienced physicians. Only a randomized controlled trial that compares diagnostic FFB and BAL with a non-invasive strategy could ultimately establish the safety profile and clinical utility of these procedures in critically ill ventilated patients. |
doi_str_mv | 10.1186/s12890-015-0104-1 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4588466</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A541424754</galeid><sourcerecordid>A541424754</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-25295b394f0dec414c167a0283a740427c9e484bc4067db8bee1a692765582f23</originalsourceid><addsrcrecordid>eNptUk1rFTEUDWKxtfoD3EjATTfT5nOS2QjlYVUouNF1yGTuzItkkmcy70l3_nQzvGdpQULIzc05557AQegdJdeU6vamUKY70hAq6yaioS_QBRWKNky07csn9Tl6XcpPQqjSkr9C56wVjHDOL9CfTfDROxuwS_tcANs41HLehdpcfIoFjymE9NvHCQ_eTjGVxTvc5xTdNtlwgBRsxsEe7ATYR-yyX1bB8IB9CHgGt7Xx1DhAXHywCwx4V9XrrbxBZ6MNBd6ezkv04-7T982X5v7b56-b2_vGVf9LwyTrZM87MZIBnKDC0VZZwjS3ShDBlOtAaNE7QVo19LoHoLbtmGql1Gxk_BJ9POru9v0Mg6uzsw1ml_1s84NJ1pvnL9FvzZQORkitq4UqcHUSyOnXHspiZl8chGAjpH0xVFHNORFyhX44QicbwPg4pqroVri5ldU7E0qKirr-D6quAWbvUoTR1_4zAj0SXE6lZBgf3VNi1kCYYyBMDYRZA2Fo5bx_-u1Hxr8E8L8J67NZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1718330456</pqid></control><display><type>article</type><title>Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>TestCollectionTL3OpenAccess</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Schnabel, R M ; van der Velden, K ; Osinski, A ; Rohde, G ; Roekaerts, P M H J ; Bergmans, D C J J</creator><creatorcontrib>Schnabel, R M ; van der Velden, K ; Osinski, A ; Rohde, G ; Roekaerts, P M H J ; Bergmans, D C J J</creatorcontrib><description>Flexible, fibreoptic bronchoscopy (FFB) and bronchoalveolar lavage (BAL) have been used for diagnostic purposes in critically ill ventilated patients. The additional diagnostic value compared to tracheal aspirations in ventilator-associated pneumonia (VAP) has been questioned. Nevertheless, BAL can provide extra information for the differential diagnosis of respiratory disease and good antibiotic stewardship. These benefits should outweigh potential hazards caused by the invasiveness of this diagnostic technique. The focus of the present study was on the clinical course and complications of patients following BAL procedures up to 24 h.
Hundred sixty-four FFB guided BAL procedures for suspected pneumonia were analysed in an observational study. The clinical course of patients was monitored by respiratory and haemodynamic data before BAL, 1 and 24 h after BAL. Complications were defined and registered. Factors associated with complications were analysed by logistic regression.
a decrease in average pO2/FiO2 ratio 1 h after BAL from 29 kPa (218 mmHg) to 25 kPa (189 mmHg) (p < 0.05) was observed which fully recovered within 24 h. Respiratory complications: the incidence of procedure related hypo-oxygenation (SaO2 ≤ 88 %) and/or bronchospasm was 9 %; a decrease of >25 % PaO2/FiO2 ratio 1 h after BAL was found in 29 % of patients; no bleeding or pneumothorax were registered. Haemodynamic complications: there were no cases of hypertension and cardiac rhythm disturbances; haemodynamic instability within the first 24 h after BAL was recorded in 22 %; this was correlated with a cardiovascular diagnosis at admission (OR 2.9; 95 % CI 1.2 - 6.7) and the presence of cardiovascular co-morbidity (OR 3.5; 95 % CI 1.5 - 8.3). The incidence of bacteraemia was 7 %. There was no case of procedure related death.
Frequently occurring haemodynamic and respiratory instability but no cases of cardiac rhythm disturbances, bleeding, pneumothorax or procedure related death were attributable to diagnostic FFB and BAL. The procedures should be conducted under careful supervision by experienced physicians. Only a randomized controlled trial that compares diagnostic FFB and BAL with a non-invasive strategy could ultimately establish the safety profile and clinical utility of these procedures in critically ill ventilated patients.</description><identifier>ISSN: 1471-2466</identifier><identifier>EISSN: 1471-2466</identifier><identifier>DOI: 10.1186/s12890-015-0104-1</identifier><identifier>PMID: 26420333</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Aged ; Anti-Bacterial Agents - therapeutic use ; Arrhythmias, Cardiac - epidemiology ; Bacteremia - epidemiology ; Bacterial pneumonia ; Bronchoalveolar Lavage ; Bronchoscopy ; Care and treatment ; Comparative analysis ; Complications and side effects ; Critical Illness ; Diagnosis ; Escherichia coli ; Escherichia coli Infections - diagnosis ; Escherichia coli Infections - drug therapy ; Female ; Health aspects ; Hemoptysis - epidemiology ; Hospital Mortality ; Humans ; Hypertension - epidemiology ; Hypoxia - epidemiology ; Logistic Models ; Male ; Medical research ; Medicine, Experimental ; Middle Aged ; Patient outcomes ; Pneumonia ; Pneumonia, Staphylococcal - diagnosis ; Pneumonia, Staphylococcal - drug therapy ; Pneumonia, Ventilator-Associated - diagnosis ; Pneumonia, Ventilator-Associated - drug therapy ; Pneumonia, Ventilator-Associated - microbiology ; Pneumothorax - epidemiology ; Postoperative Complications - epidemiology ; Pseudomonas aeruginosa ; Pseudomonas Infections - diagnosis ; Pseudomonas Infections - drug therapy ; Respiration, Artificial ; Staphylococcus aureus</subject><ispartof>BMC pulmonary medicine, 2015-09, Vol.15 (1), p.107-107, Article 107</ispartof><rights>COPYRIGHT 2015 BioMed Central Ltd.</rights><rights>Schnabel et al. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-25295b394f0dec414c167a0283a740427c9e484bc4067db8bee1a692765582f23</citedby><cites>FETCH-LOGICAL-c466t-25295b394f0dec414c167a0283a740427c9e484bc4067db8bee1a692765582f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588466/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588466/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26420333$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schnabel, R M</creatorcontrib><creatorcontrib>van der Velden, K</creatorcontrib><creatorcontrib>Osinski, A</creatorcontrib><creatorcontrib>Rohde, G</creatorcontrib><creatorcontrib>Roekaerts, P M H J</creatorcontrib><creatorcontrib>Bergmans, D C J J</creatorcontrib><title>Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients</title><title>BMC pulmonary medicine</title><addtitle>BMC Pulm Med</addtitle><description>Flexible, fibreoptic bronchoscopy (FFB) and bronchoalveolar lavage (BAL) have been used for diagnostic purposes in critically ill ventilated patients. The additional diagnostic value compared to tracheal aspirations in ventilator-associated pneumonia (VAP) has been questioned. Nevertheless, BAL can provide extra information for the differential diagnosis of respiratory disease and good antibiotic stewardship. These benefits should outweigh potential hazards caused by the invasiveness of this diagnostic technique. The focus of the present study was on the clinical course and complications of patients following BAL procedures up to 24 h.
Hundred sixty-four FFB guided BAL procedures for suspected pneumonia were analysed in an observational study. The clinical course of patients was monitored by respiratory and haemodynamic data before BAL, 1 and 24 h after BAL. Complications were defined and registered. Factors associated with complications were analysed by logistic regression.
a decrease in average pO2/FiO2 ratio 1 h after BAL from 29 kPa (218 mmHg) to 25 kPa (189 mmHg) (p < 0.05) was observed which fully recovered within 24 h. Respiratory complications: the incidence of procedure related hypo-oxygenation (SaO2 ≤ 88 %) and/or bronchospasm was 9 %; a decrease of >25 % PaO2/FiO2 ratio 1 h after BAL was found in 29 % of patients; no bleeding or pneumothorax were registered. Haemodynamic complications: there were no cases of hypertension and cardiac rhythm disturbances; haemodynamic instability within the first 24 h after BAL was recorded in 22 %; this was correlated with a cardiovascular diagnosis at admission (OR 2.9; 95 % CI 1.2 - 6.7) and the presence of cardiovascular co-morbidity (OR 3.5; 95 % CI 1.5 - 8.3). The incidence of bacteraemia was 7 %. There was no case of procedure related death.
Frequently occurring haemodynamic and respiratory instability but no cases of cardiac rhythm disturbances, bleeding, pneumothorax or procedure related death were attributable to diagnostic FFB and BAL. The procedures should be conducted under careful supervision by experienced physicians. Only a randomized controlled trial that compares diagnostic FFB and BAL with a non-invasive strategy could ultimately establish the safety profile and clinical utility of these procedures in critically ill ventilated patients.</description><subject>Aged</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Arrhythmias, Cardiac - epidemiology</subject><subject>Bacteremia - epidemiology</subject><subject>Bacterial pneumonia</subject><subject>Bronchoalveolar Lavage</subject><subject>Bronchoscopy</subject><subject>Care and treatment</subject><subject>Comparative analysis</subject><subject>Complications and side effects</subject><subject>Critical Illness</subject><subject>Diagnosis</subject><subject>Escherichia coli</subject><subject>Escherichia coli Infections - diagnosis</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Female</subject><subject>Health aspects</subject><subject>Hemoptysis - epidemiology</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Hypertension - epidemiology</subject><subject>Hypoxia - epidemiology</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Middle Aged</subject><subject>Patient outcomes</subject><subject>Pneumonia</subject><subject>Pneumonia, Staphylococcal - diagnosis</subject><subject>Pneumonia, Staphylococcal - drug therapy</subject><subject>Pneumonia, Ventilator-Associated - diagnosis</subject><subject>Pneumonia, Ventilator-Associated - drug therapy</subject><subject>Pneumonia, Ventilator-Associated - microbiology</subject><subject>Pneumothorax - epidemiology</subject><subject>Postoperative Complications - epidemiology</subject><subject>Pseudomonas aeruginosa</subject><subject>Pseudomonas Infections - diagnosis</subject><subject>Pseudomonas Infections - drug therapy</subject><subject>Respiration, Artificial</subject><subject>Staphylococcus aureus</subject><issn>1471-2466</issn><issn>1471-2466</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptUk1rFTEUDWKxtfoD3EjATTfT5nOS2QjlYVUouNF1yGTuzItkkmcy70l3_nQzvGdpQULIzc05557AQegdJdeU6vamUKY70hAq6yaioS_QBRWKNky07csn9Tl6XcpPQqjSkr9C56wVjHDOL9CfTfDROxuwS_tcANs41HLehdpcfIoFjymE9NvHCQ_eTjGVxTvc5xTdNtlwgBRsxsEe7ATYR-yyX1bB8IB9CHgGt7Xx1DhAXHywCwx4V9XrrbxBZ6MNBd6ezkv04-7T982X5v7b56-b2_vGVf9LwyTrZM87MZIBnKDC0VZZwjS3ShDBlOtAaNE7QVo19LoHoLbtmGql1Gxk_BJ9POru9v0Mg6uzsw1ml_1s84NJ1pvnL9FvzZQORkitq4UqcHUSyOnXHspiZl8chGAjpH0xVFHNORFyhX44QicbwPg4pqroVri5ldU7E0qKirr-D6quAWbvUoTR1_4zAj0SXE6lZBgf3VNi1kCYYyBMDYRZA2Fo5bx_-u1Hxr8E8L8J67NZ</recordid><startdate>20150929</startdate><enddate>20150929</enddate><creator>Schnabel, R M</creator><creator>van der Velden, K</creator><creator>Osinski, A</creator><creator>Rohde, G</creator><creator>Roekaerts, P M H J</creator><creator>Bergmans, D C J J</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150929</creationdate><title>Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients</title><author>Schnabel, R M ; van der Velden, K ; Osinski, A ; Rohde, G ; Roekaerts, P M H J ; Bergmans, D C J J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-25295b394f0dec414c167a0283a740427c9e484bc4067db8bee1a692765582f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Arrhythmias, Cardiac - epidemiology</topic><topic>Bacteremia - epidemiology</topic><topic>Bacterial pneumonia</topic><topic>Bronchoalveolar Lavage</topic><topic>Bronchoscopy</topic><topic>Care and treatment</topic><topic>Comparative analysis</topic><topic>Complications and side effects</topic><topic>Critical Illness</topic><topic>Diagnosis</topic><topic>Escherichia coli</topic><topic>Escherichia coli Infections - diagnosis</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Female</topic><topic>Health aspects</topic><topic>Hemoptysis - epidemiology</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Hypertension - epidemiology</topic><topic>Hypoxia - epidemiology</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Middle Aged</topic><topic>Patient outcomes</topic><topic>Pneumonia</topic><topic>Pneumonia, Staphylococcal - diagnosis</topic><topic>Pneumonia, Staphylococcal - drug therapy</topic><topic>Pneumonia, Ventilator-Associated - diagnosis</topic><topic>Pneumonia, Ventilator-Associated - drug therapy</topic><topic>Pneumonia, Ventilator-Associated - microbiology</topic><topic>Pneumothorax - epidemiology</topic><topic>Postoperative Complications - epidemiology</topic><topic>Pseudomonas aeruginosa</topic><topic>Pseudomonas Infections - diagnosis</topic><topic>Pseudomonas Infections - drug therapy</topic><topic>Respiration, Artificial</topic><topic>Staphylococcus aureus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schnabel, R M</creatorcontrib><creatorcontrib>van der Velden, K</creatorcontrib><creatorcontrib>Osinski, A</creatorcontrib><creatorcontrib>Rohde, G</creatorcontrib><creatorcontrib>Roekaerts, P M H J</creatorcontrib><creatorcontrib>Bergmans, D C J J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC pulmonary medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schnabel, R M</au><au>van der Velden, K</au><au>Osinski, A</au><au>Rohde, G</au><au>Roekaerts, P M H J</au><au>Bergmans, D C J J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients</atitle><jtitle>BMC pulmonary medicine</jtitle><addtitle>BMC Pulm Med</addtitle><date>2015-09-29</date><risdate>2015</risdate><volume>15</volume><issue>1</issue><spage>107</spage><epage>107</epage><pages>107-107</pages><artnum>107</artnum><issn>1471-2466</issn><eissn>1471-2466</eissn><abstract>Flexible, fibreoptic bronchoscopy (FFB) and bronchoalveolar lavage (BAL) have been used for diagnostic purposes in critically ill ventilated patients. The additional diagnostic value compared to tracheal aspirations in ventilator-associated pneumonia (VAP) has been questioned. Nevertheless, BAL can provide extra information for the differential diagnosis of respiratory disease and good antibiotic stewardship. These benefits should outweigh potential hazards caused by the invasiveness of this diagnostic technique. The focus of the present study was on the clinical course and complications of patients following BAL procedures up to 24 h.
Hundred sixty-four FFB guided BAL procedures for suspected pneumonia were analysed in an observational study. The clinical course of patients was monitored by respiratory and haemodynamic data before BAL, 1 and 24 h after BAL. Complications were defined and registered. Factors associated with complications were analysed by logistic regression.
a decrease in average pO2/FiO2 ratio 1 h after BAL from 29 kPa (218 mmHg) to 25 kPa (189 mmHg) (p < 0.05) was observed which fully recovered within 24 h. Respiratory complications: the incidence of procedure related hypo-oxygenation (SaO2 ≤ 88 %) and/or bronchospasm was 9 %; a decrease of >25 % PaO2/FiO2 ratio 1 h after BAL was found in 29 % of patients; no bleeding or pneumothorax were registered. Haemodynamic complications: there were no cases of hypertension and cardiac rhythm disturbances; haemodynamic instability within the first 24 h after BAL was recorded in 22 %; this was correlated with a cardiovascular diagnosis at admission (OR 2.9; 95 % CI 1.2 - 6.7) and the presence of cardiovascular co-morbidity (OR 3.5; 95 % CI 1.5 - 8.3). The incidence of bacteraemia was 7 %. There was no case of procedure related death.
Frequently occurring haemodynamic and respiratory instability but no cases of cardiac rhythm disturbances, bleeding, pneumothorax or procedure related death were attributable to diagnostic FFB and BAL. The procedures should be conducted under careful supervision by experienced physicians. Only a randomized controlled trial that compares diagnostic FFB and BAL with a non-invasive strategy could ultimately establish the safety profile and clinical utility of these procedures in critically ill ventilated patients.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>26420333</pmid><doi>10.1186/s12890-015-0104-1</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1471-2466 |
ispartof | BMC pulmonary medicine, 2015-09, Vol.15 (1), p.107-107, Article 107 |
issn | 1471-2466 1471-2466 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4588466 |
source | MEDLINE; Springer Nature - Complete Springer Journals; TestCollectionTL3OpenAccess; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access; Springer Nature OA Free Journals |
subjects | Aged Anti-Bacterial Agents - therapeutic use Arrhythmias, Cardiac - epidemiology Bacteremia - epidemiology Bacterial pneumonia Bronchoalveolar Lavage Bronchoscopy Care and treatment Comparative analysis Complications and side effects Critical Illness Diagnosis Escherichia coli Escherichia coli Infections - diagnosis Escherichia coli Infections - drug therapy Female Health aspects Hemoptysis - epidemiology Hospital Mortality Humans Hypertension - epidemiology Hypoxia - epidemiology Logistic Models Male Medical research Medicine, Experimental Middle Aged Patient outcomes Pneumonia Pneumonia, Staphylococcal - diagnosis Pneumonia, Staphylococcal - drug therapy Pneumonia, Ventilator-Associated - diagnosis Pneumonia, Ventilator-Associated - drug therapy Pneumonia, Ventilator-Associated - microbiology Pneumothorax - epidemiology Postoperative Complications - epidemiology Pseudomonas aeruginosa Pseudomonas Infections - diagnosis Pseudomonas Infections - drug therapy Respiration, Artificial Staphylococcus aureus |
title | Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T15%3A22%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20course%20and%20complications%20following%20diagnostic%20bronchoalveolar%20lavage%20in%20critically%20ill%20mechanically%20ventilated%20patients&rft.jtitle=BMC%20pulmonary%20medicine&rft.au=Schnabel,%20R%20M&rft.date=2015-09-29&rft.volume=15&rft.issue=1&rft.spage=107&rft.epage=107&rft.pages=107-107&rft.artnum=107&rft.issn=1471-2466&rft.eissn=1471-2466&rft_id=info:doi/10.1186/s12890-015-0104-1&rft_dat=%3Cgale_pubme%3EA541424754%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1718330456&rft_id=info:pmid/26420333&rft_galeid=A541424754&rfr_iscdi=true |